Where 2020 marked a year of crisis, 2021 was a year of transformation – and both were driven in large part by the continuing effects of COVID-19. The pandemic brought profound changes to how patients access their healthcare services – the convenient neighborhood pharmacy has become a new epicenter of healthcare. And Omnicell, with our Purpose of providing A Better Way to offer pharmacy services, is core to the evolution of people’s relationship to how they access their trusted healthcare.
The growing digitalization of healthcare services – a long-growing trend that accelerated during the pandemic – has altered virtually every corner of healthcare. With pharmacies playing an ever-greater role in healthcare, we believe Omnicell is perfectly positioned to support pharmacists as they streamline their workflows and endeavor to improve patient health outcomes. Because of, and amidst, these industry-wide and global transformations, Omnicell in 2021 achieved a number of milestones and leveraged significant opportunities. In addition to bringing in record revenues, we completed several acquisitions of like-minded businesses – FDS Amplicare™, ReCept™, and MarkeTouch Media™ that will further assist pharmacies in achieving our shared Vision of the Autonomous Pharmacy, which leads us to A Better Way of providing healthcare access and improving health outcomes in the communities where we live, work, and serve. This Better Way isn’t something we have to do, it’s something we GET to do for the communities we serve. It’s not only a business model for future growth, but it’s Doing the Right Thing to help pharmacists, and pharmacies, provide healthcare to those in need and practice at the top of their license. The dual purpose of Doing Right for others, as well as strategically planning for the future, is a fantastic opportunity for Omnicell.
As we re-open our doors to welcome employees back to the workplace post-Covid-19 surges, we are committed to continuing our legacy of making a difference in our communities through charitable donations and volunteerism. Omnicell has partnered with a giving and volunteering platform that serves as a one-stop shop for Omnicell’s charitable initiatives, allowing us to achieve a global impact on both an organizational and societal level through consolidating efforts, donating funds, company matching, in-kind donations, and volunteering.
In 2022, we will celebrate the 30th anniversary of Omnicell’s founding. Countless exciting changes have taken place since 1992, and we eagerly anticipate the road ahead. Omnicell is forging ahead into a new era of delivering optimal healthcare solutions that are designed to improve outcomes. We hope this inspires others to create A Better Way, together.
Omnicell is in an evolutionary stage, and we think there is no better time for us to embark on Our Better Way to provide products and services to our customers. Our people, our places, and our products have undergone transformative realignment to our Vision of the Autonomous Pharmacy. We are on a path to Design for Excellence, incorporating not just Privacy by Design, but ESG by Design as well, scrutinizing the products we deliver, the materials we use, and the supply chain we rely upon to help facilitate the global objective of limiting global temperature rise to 1.5° Celsius by 2030. Moving data to the cloud is just one step forward, while refreshing our product, go-to-market, customer experience, and platform architecture strategies. With the completion of our first Materiality Assessment in 2021, we are “all in” for being responsible corporate citizens in the world as it relates to our Purpose, Mission, Vision, and Values.
Working with the various teams that have brought this report together is a privilege. It’s not every CEO that characterizes Corporate Responsibility as something “we GET to do,” and not something “we have to do.” Nor his view that by doing more, we are richer for the experience of Doing the Right Thing. But that’s who Randall Lipps is, and how he feels about Our Better Way. Sentiments like these are what make my life’s work easy, and an honor and a privilege to be part of this organization during this exciting time, working among such passionate transformers in the industry. I can’t wait to see what tomorrow brings!
We are ‘all in’ for being responsible corporate citizens in the world as it relates to our Purpose, Mission, Vision, and Values.
Omnicell is a leading provider of solutions targeting patient safety and operational efficiency in healthcare facilities. From medication delivery to administration, Omnicell’s systems are responsible for storing, packaging, barcoding, ordering, and issuing medications for our customers. Our data-driven, automated medication management and adherence solutions have earned industry accolades, and enable our customers around the world – health systems, hospitals, care homes, pharmacies, and health plans – to continue to play a pivotal role in patient care and population health.
September 9, 2021, we completed the acquisition of FDS Amplicare, a pharmacy technology provider. The FDS Amplicare acquisition adds a comprehensive and complementary suite of SaaS financial management, analytics, and population health solutions to our EnlivenHealth offering. In addition, FDS Amplicare’s nationwide network of independent retail pharmacies significantly expands EnlivenHealth’s broad industry footprint centered on leading pharmacy chains.
We then completed the acquisition of ReCept on December 29, 2021, a provider of specialty pharmacy management services. The addition of ReCept’s specialty pharmacy management services for health systems, provider groups, and federally qualified health centers expands Omnicell’s Advanced Services portfolio in an effort to address the growing and complex specialty pharmacy market.
Our last strategic acquisition for 2021 was the purchase of MarkeTouch Media, a pharmacy software solutions provider, on December 31, 2021. The MarkeTouch Media acquisition adds mobile and web-based technology and patient engagement solutions, which are expected to expand the footprint of EnlivenHealth across the retail pharmacy sector, while enhancing potential growth opportunities in new market segments like specialty pharmacy and pharmacy benefits management.
Our vision is to transform the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced service offerings. We believe our connected devices, products, and solutions, which unite automation, intelligence, and services, will help our customers harness the power of data and analytics, and deliver improved patient outcomes. Guided by our core values and founding principles, as well as our commitment to creating positive change, we will deliver A Better Way – of doing business, enabling our customers’ success, engaging our employees, and supporting the communities where we live and serve.
Our solutions are installed around the world, and institutional and retail pharmacy customers leverage our innovative medication-adherence and population-health solutions. With close to 160,000 of our devices installed in hospitals around the globe, dispensing close to five million doses daily, and over two million users, we play a critical role in day-to-day pharmacy operations.
Through our medication management platform that spans the continuum of care, Omnicell provides the intelligent infrastructure necessary to advance the Autonomous Pharmacy and reach the industry vision. By developing and delivering a combination of technology, analytics, and expert services utilizing a single, cloud-based platform, we believe we will empower healthcare and pharmacy providers to increase healthcare value and improve patient outcomes. Institutional and retail pharmacies across North America, the United Kingdom, Germany, and Australia leverage our innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. Our products are available in a variety of languages including Traditional Chinese, Simplified Chinese, Japanese, Korean, French, Swedish, Dutch, Spanish, and German.
Headquartered in Mountain View, California, Omnicell has a global presence with approximately 3,800 employees worldwide (as of December 31, 2021). In addition to our facilities in the United States, we have offices in Australia, China, France, Germany, India, Italy, the United Arab Emirates, and the United Kingdom.
Omnicell is governed by a diverse and independent Board of Directors currently comprised of ten highly qualified directors, eight of whom are independent and three of whom come from diverse backgrounds. The diversity of our Board members reflects our continuing efforts to achieve a diversity of viewpoints, experiences, and knowledge, as well as ethnicities and gender.
in total revenues
in product bookings
The following are trademarks or registered trademarks of current Omnicell products/brands:
Omnicell® the Omnicell logo OmniCenter® Omnicell One™ SafetyStock® SinglePointe® OnDemand® SureMed® AccuFlex® Detect-Rx® EnlivenHealth® Time My Meds® Pharmacy Line® Connect-Rx® MedCarousel® ROBOT-Rx® Performance Center™ AcuDose-Rx™ Omnicell 340B™ Care Scheduler™ FDS Amplicare™ ReCept™ MarkeTouch Media™
Through the execution of our strategic plan, we have delivered strong results and created significant value for our shareholders.
As COVID-19 continued to take its toll on the world’s populations, Omnicell continued to support our employees and customers through it all. We maintained our work-from-home mandate for non-essential personnel throughout 2021 and into 2022, implemented additional safety protocols for field and service technicians, while pivoting to address our customers’ most urgent needs on the front lines, including the launch of our CareScheduler application (available through EnlivenHealth), assisting with vaccine scheduling and reporting in retail pharmacies across the United States.
In 2021, we shipped 11,500 N95 masks, 46,000 surgical masks, 26,300 pairs of nitrile gloves, and more than 5,200 fluid ounces of hand sanitizer, as well as lateral flow tests in the EU, to our front-line employees. We continue to monitor the dynamic and rapidly changing nature of the pandemic everywhere we work, and are committed to keeping our people safe while supporting life-saving care for patients around the world. We will sustain this support for our employees and our customers globally until resolution of the pandemic.
